Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature

Introduction. Loss of function mutations of CYP24A1 gene, which is involved in vitamin D catabolism, cause vitamin D-mediated PTH-independent hypercalcemia. The phenotype varies from life-threatening forms in the infancy to milder forms in the adulthood. Case Presentation. We report a case of a 17-y...

Full description

Bibliographic Details
Main Authors: Daniele Cappellani, Alessandro Brancatella, Martin Kaufmann, Angelo Minucci, Edda Vignali, Domenico Canale, Elisa De Paolis, Ettore Capoluongo, Filomena Cetani, Glenville Jones, Claudio Marcocci
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Case Reports in Endocrinology
Online Access:http://dx.doi.org/10.1155/2019/4982621
id doaj-9feecd423ffa416dbd16164f771ef90c
record_format Article
spelling doaj-9feecd423ffa416dbd16164f771ef90c2020-11-24T21:50:08ZengHindawi LimitedCase Reports in Endocrinology2090-65012090-651X2019-01-01201910.1155/2019/49826214982621Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the LiteratureDaniele Cappellani0Alessandro Brancatella1Martin Kaufmann2Angelo Minucci3Edda Vignali4Domenico Canale5Elisa De Paolis6Ettore Capoluongo7Filomena Cetani8Glenville Jones9Claudio Marcocci10Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyDepartment of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyDepartment of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, CanadaFondazione Policlinico Universitario A. Gemelli IRCCS, Roma, ItalyDepartment of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyDepartment of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS, Roma, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS, Roma, ItalyDepartment of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyDepartment of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, CanadaDepartment of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa, Pisa, ItalyIntroduction. Loss of function mutations of CYP24A1 gene, which is involved in vitamin D catabolism, cause vitamin D-mediated PTH-independent hypercalcemia. The phenotype varies from life-threatening forms in the infancy to milder forms in the adulthood. Case Presentation. We report a case of a 17-year-old woman with a history of nephrolithiasis, mild PTH-independent hypercalcemia (10,5mg/dL), and high serum 1,25(OH)2D concentrations (107pg/mL). Other causes of hypercalcemia associated with the above biochemical signature were excluded. Family history revealed nephrolithiasis in the sister. Blood testing in first-degree relatives showed serum PTH in the low-normal range and 1,25(OH)2D at the upper normal limit or slightly elevated. The CYP24A1 gene analysis revealed a known homozygous loss-of-function pathogenic variant (c.428_430delAAG, rs777676129, p.Glu143del). The panel of vitamin D metabolites evaluated by liquid chromatography showed the typical profile of CYP24A1 mutations, namely, low 24,25(OH)2D3, elevated 25(OH)D3:24,25(OH)2D3 ratio, and undetectable 1,24,25(OH)3D3. The parents and both the siblings harbored the same variant in heterozygosis. We decided for a watchful waiting approach and the patient remained clinically and biochemically stable over a 24-month followup. Conclusion. CYP24A1 gene mutations should be considered in cases of PTH-independent hypercalcemia, once that more common causes (hypercalcemia of malignancy, granulomatous diseases, and vitamin D intoxication) have been ruled out.http://dx.doi.org/10.1155/2019/4982621
collection DOAJ
language English
format Article
sources DOAJ
author Daniele Cappellani
Alessandro Brancatella
Martin Kaufmann
Angelo Minucci
Edda Vignali
Domenico Canale
Elisa De Paolis
Ettore Capoluongo
Filomena Cetani
Glenville Jones
Claudio Marcocci
spellingShingle Daniele Cappellani
Alessandro Brancatella
Martin Kaufmann
Angelo Minucci
Edda Vignali
Domenico Canale
Elisa De Paolis
Ettore Capoluongo
Filomena Cetani
Glenville Jones
Claudio Marcocci
Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature
Case Reports in Endocrinology
author_facet Daniele Cappellani
Alessandro Brancatella
Martin Kaufmann
Angelo Minucci
Edda Vignali
Domenico Canale
Elisa De Paolis
Ettore Capoluongo
Filomena Cetani
Glenville Jones
Claudio Marcocci
author_sort Daniele Cappellani
title Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature
title_short Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature
title_full Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature
title_fullStr Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature
title_full_unstemmed Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature
title_sort hereditary hypercalcemia caused by a homozygous pathogenic variant in the cyp24a1 gene: a case report and review of the literature
publisher Hindawi Limited
series Case Reports in Endocrinology
issn 2090-6501
2090-651X
publishDate 2019-01-01
description Introduction. Loss of function mutations of CYP24A1 gene, which is involved in vitamin D catabolism, cause vitamin D-mediated PTH-independent hypercalcemia. The phenotype varies from life-threatening forms in the infancy to milder forms in the adulthood. Case Presentation. We report a case of a 17-year-old woman with a history of nephrolithiasis, mild PTH-independent hypercalcemia (10,5mg/dL), and high serum 1,25(OH)2D concentrations (107pg/mL). Other causes of hypercalcemia associated with the above biochemical signature were excluded. Family history revealed nephrolithiasis in the sister. Blood testing in first-degree relatives showed serum PTH in the low-normal range and 1,25(OH)2D at the upper normal limit or slightly elevated. The CYP24A1 gene analysis revealed a known homozygous loss-of-function pathogenic variant (c.428_430delAAG, rs777676129, p.Glu143del). The panel of vitamin D metabolites evaluated by liquid chromatography showed the typical profile of CYP24A1 mutations, namely, low 24,25(OH)2D3, elevated 25(OH)D3:24,25(OH)2D3 ratio, and undetectable 1,24,25(OH)3D3. The parents and both the siblings harbored the same variant in heterozygosis. We decided for a watchful waiting approach and the patient remained clinically and biochemically stable over a 24-month followup. Conclusion. CYP24A1 gene mutations should be considered in cases of PTH-independent hypercalcemia, once that more common causes (hypercalcemia of malignancy, granulomatous diseases, and vitamin D intoxication) have been ruled out.
url http://dx.doi.org/10.1155/2019/4982621
work_keys_str_mv AT danielecappellani hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature
AT alessandrobrancatella hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature
AT martinkaufmann hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature
AT angelominucci hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature
AT eddavignali hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature
AT domenicocanale hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature
AT elisadepaolis hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature
AT ettorecapoluongo hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature
AT filomenacetani hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature
AT glenvillejones hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature
AT claudiomarcocci hereditaryhypercalcemiacausedbyahomozygouspathogenicvariantinthecyp24a1geneacasereportandreviewoftheliterature
_version_ 1725885102744928256